EnglishOnly available as part of a course
|Summary||This e-learning module has been developed in collaboration with International Society of Geriatric Oncology.|
The information in this module is based on the manuscript: ‘Radiopharmaceuticals in the elderly cancer patient: practical considerations, with a focus of prostate cancer therapy - A proposition paper from a SIOG task force’.
This module was published in May 2016.
This module is for medical practitioners who wish to gain knowledge on the SIOG recommended guidelines for the management of Radiopharmaceuticals in older patients.
Learners will be able to receive 1 EACCME point upon successful completion of this module.
|Only available as part of course(s):|
This module requires the learner to have a good, stable internet connection and can run on Internet Explorer 7 and above, Mozilla Firefox, Google Chrome and Opera on either Windows or MacOS. Flash Add-on is also required to run this module.
If you are viewing this module on an iPad (through a browser), please download the free Articulate Mobile Player beforehand. Other tablet devices may not be compatible - please check for Flash compatability.
If you are experiencing technical difficulties, please contact email@example.com and we will get back to you as soon as possible.
Production of this module was funded by the International Society of Geriatric Oncology (SIOG) and by an unrestricted grant from Bayer.
This e-learning module is valid for one year after publication and will expire on 27th May 2018
ecancer and Prof John O. Prior, Nuclear Medicine and Molecular Imaging Office, Rue du Bugnon, Lausanne, Switzerland have no actual or potential conflict of interest whatsoever which impinges on the making, peer reviewing and dissemination of this e-learning module which was made possible through an unrestricted educational grant from Bayer.